Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Nausea. Found 7 abstracts

Moore KN, Martin LP, O'Malley DM, Matulonis UA, Konner JA, Perez RP, Bauer TM, Ruiz-Soto R, Birrer MJ. Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. J Clin Oncol. 2017 Apr;35(10):1112-8.   PMCID: PMC5559878
Infante JR, Dees EC, Olszanski AJ, Dhuria SV, Sen S, Cameron S, Cohen RB. Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol. 2014 Oct;32(28):3103-10.
Mateo J, Berlin J, de Bono JS, Cohen RB, Keedy V, Mugundu G, Zhang L, Abbattista A, Davis C, Gallo Stampino C, Borghaei H. A first-in-human study of the anti-alpha5beta1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Nov;74(5):1039-46.   PMCID: Pmc4209234
Small W, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20;26(6):942-7.
Hudes G, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellman M, Nordle O, Eriksson B, Miller L, Cisar L, Kopreski M, Viaro D, Hartley-Asp B. Phase I clinical and pharmacologic trial of intravenous estramustine phosphate. J Clin Oncol. 2002 Feb 15;20(4):1115-27.
Haas N, Roth B, Garay C, Yeslow G, Entmacher M, Weinstein A, Rogatko A, Babb J, Minnitti C, Flinker D, Gillon T, Hudes G. Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer. Urology. 2001 Jul;58(1):59-64.
O'Dwyer PJ, Laub PB, DeMaria D, Qian M, Reilly D, Giantonio B, Johnston AL, Wu EY, Bauman L, Clendeninn NJ, Gallo JM. Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion. Clin Cancer Res. 1996 Oct;2(10):1685-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Nausea

Nausea chemically induced Aged adverse effects drug therapy Male therapeutic use Adult 80 and over Aged Female Middle Aged Treatment Outcome Fatigue Vomiting Intravenous Infusions pharmacokinetics pathology adverse administration & dosage Neoplasms effects Drug Dose-Response Relationship Human Neoplasm Drug Resistance Area Under Curve metabolism Hypotension Middle Age immunology Diarrhea Oral Administration antagonists & inhibitors Metabolic Clearance Rate Drug Administration Schedule Prostatic Neoplasms Monoclonal Antibodies-Humanized Non-US Gov't Support Estramustine Antineoplastic Agents Disease-Free Survival drug effects Integrin alpha5beta1 CA-19-9 Antigen Hormonal Antineoplastic Agents Maytansine Adenocarcinoma US Gov't Support-PHS analogs & Flushing Thrombosis Antineoplastic Antimetabolites Bilirubin agonists derivatives Thiazoles Ovarian Neoplasms Retreatment Disease Progression Antineoplastic Combined Chemotherapy Protocols Inhibitor of Apoptosis Proteins Syndrome Thymidylate Synthase Platinum Compounds radiotherapy Adjuvant Chemotherapy Cytokines Tablets Neutropenia blood chemistry Anaphylaxis Conformal Radiotherapy surgery Biological Tumor Markers secondary Liver Diseases Peritoneal Neoplasms Pharmaceutical Solutions secretion Fallopian Tube Neoplasms Aspartate Aminotransferases Neoplasm Staging Deoxycytidine Immunoconjugates Adjuvant Radiotherapy use Gonadorelin Folate Receptor 1 Thrombophlebitis Enzyme Inhibitors Pancreatic Neoplasms Pain Indoles Response Evaluation Criteria in Solid Tumors Paclitaxel Vision Disorders therapy Liver etiology Edema analogs & derivatives Fever drug Biological Availability Alanine Transaminase analysis Survival Analysis therapeutic
Last updated on Wednesday, February 05, 2020